Cargando…
Drug Therapies for the Management of Sickle Cell Disease
Sickle cell disease (SCD) afflicts millions of people worldwide but is referred to as an orphan disease in the United States. Over the past several decades, there has been an increasing understanding of the pathophysiology of SCD and its complications. While most individuals with SCD in resource-ric...
Autores principales: | Rai, Parul, Ataga, Kenneth I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388199/ https://www.ncbi.nlm.nih.gov/pubmed/32765834 http://dx.doi.org/10.12688/f1000research.22433.1 |
Ejemplares similares
-
The glomerulopathy of sickle cell disease
por: Ataga, Kenneth I, et al.
Publicado: (2014) -
Clinical Implications of the Association of Fetal Hemoglobin with Peripheral Oxygen Saturation in Sickle Cell Disease
por: Abdulmalik, Osheiza, et al.
Publicado: (2017) -
End Stage Kidney Disease Outcomes in Children and Young Adults with Sickle Cell Disease in the United States Renal Data System
por: Zahr, Rima S., et al.
Publicado: (2023) -
Association of Coagulation Activation with Clinical Complications in Sickle Cell Disease
por: Ataga, Kenneth I., et al.
Publicado: (2012) -
Sex differences in progression of kidney disease in sickle cell disease
por: Ataga, Kenneth I., et al.
Publicado: (2022)